Thermo Fisher adds to Nunc roller bottle portfolio

Published: 14-Oct-2011
Manufacturing Analysis Pharmaceutical

Now available in a wider choice of materials and finishes

Thermo Fisher Scientific has expanded its portfolio of Thermo Scientific Nunc roller bottles for cell culture production. To address the expansion of the global bioproduction market, these bottles are now available in a wider choice of materials and surface treatments.

The new bottles are used for adherent cell culture applications in the production of vaccines and monoclonal antibody based biopharmaceuticals. They are part of an expansive portfolio of bioprocess consumables supported by Thermo Fisher’s global manufacturing, supply and service.

Nunc roller bottles are available in either polyethylene terephthalate (PETG) or polystyrene (PS).

Nunc InVitro PETG roller bottles withstand freezing and thawing and are available with a smooth internal surface or pleated design for increased cell growth and product yield.

The Nunc TufRol PS roller bottles have vertical pleats that are easier to empty and include indentions at the bottom for one-handed manipulation. Because Nunc T-flasks and cell factory systems are also made of polystyrene, TufRol PS roller bottles enable scientists seamlessly to develop bioproduction processes, from research to production scale.

When ordering bottles, customers can specify their preferred service treatment, including poly-d-lysine for cells that are difficult to grow or vented closures to facilitate gas exchange.

All Nunc roller bottles are manufactured in facilities that comply with cGMP, ISO 9001:2008 and ISO 13485:2003 quality standards, using polymers that are certified USP Class VI. Products are packaged and shipped in sterile condition and printed with a lot number to ensure traceability.

  • Companies:
  • Thermo Fisher Scientific
See more

You may also like

Manufacturing

Thermo Fisher Scientific highlights its new accelerator drug development solutions at CPHI Frankfurt 2025

Read more
The company has also announced a collaboration with OpenAI as well as a new digital toolbox, OSDPredict, which combines AI and machine learning models to predict formulation behaviour in small-molecule development

Trending Articles

  1. Thermo Fisher Scientific highlights its new accelerator drug development solutions at CPHI Frankfurt 2025 The company has also announced a collaboration with OpenAI as well as a new digital toolbox, OSDPredict, which combines AI and machine learning models to predict formulation behaviour in small-molecule development
  2. Merck Life Science announces closure of Arklow facility Merck has said it will close the plant in Co Wicklow, Ireland, by the end of 2028, with the loss of 100 jobs
  3. Aseptic spray drying: Transforming biotherapeutics for a new era With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications
  4. Sensum Sensum specialises in the development and production of automatic visual inspection systems for the pharmaceutical and nutraceutical industry.

You may also like

Manufacturing

Thermo Fisher Scientific highlights its new accelerator drug development solutions at CPHI Frankfurt 2025

The company has also announced a collaboration with OpenAI as well as a new digital toolbox, OSDPredict, which combines AI and machine learning models to predict formulation behaviour in small-molecule development
Manufacturing

Thermo Fisher expands collaboration Multiply Labs for automated cell therapy manufacturing

The strategic collaboration will aim to integrate robot automation with the Gibco CTS DynaCellect Magnetic Separation System for a more efficient manufacturing process
Manufacturing

Thermo Fisher Scientific opens manufacturing centre of excellence site in North Carolina

New manufacturing facility in Mebane (NC, US) site to significantly increase laboratory pipette production in the US
Manufacturing

Thermo Fisher teams up with Xcellbio to further cell and gene therapy research

The pair will focus on Treg and TIL research, with the intention of developing therapeutics for autoimmune and solid tumour diseases
Manufacturing

Thermo Fisher's Accelerator CDMO and CRO solutions can slash drug development times by 3 years, study finds

The centralised solution can streamline the drug development process, facilitating the rapid commercialisation of new therapeutics
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Accelerating therapeutic manufacturing with smart and sustainable technologies

In this article, John Puglia, Senior Director of Research and Development, Single-Use Technologies, at Thermo Fisher Scientific, explores how innovative technologies are revolutionising biomanufacturing for a smarter, more sustainable future
Manufacturing

Ethris and Thermo Fisher Scientific to provide mRNA technology to biopharma market

Ethris will combine its mRNA technology platforms with Thermo Fisher's GMP manufacturing capacity to serve the biopharmaceutical market
Subscribe now